ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The Role of Gut Microbiota in Tacrolimus Blood Level Fluctuation, Time in Therapeutic Range and AlloSure Donor Derived Cell-Free DNA, Controlling for CYP3A5

M. Nayebpour1, N. Koizumi1, J. Melancon2, M. Hasan2

1George Mason University, Arlington, VA, 2George Washington University Hospital, Washington, DC

Meeting: 2022 American Transplant Congress

Abstract number: 1695

Keywords: African-American, Dosage, Gene expression, Immunosuppression

Topic: Clinical Science » Kidney » 38 - Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Information

Session Name: Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Type: Poster Abstract

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: High tacrolimus variability (TV), low time in therapeutic range (TTR) and high percentage of donor derived cell-free DNA (dd-cfDNA) are associated with acute kidney rejection and graft loss. Due to the narrow therapeutic index of tacrolimus (TAC), African American patients usually require higher dose of TAC caused by expression of CYP3A5. The gut microbiota affects metabolization of TAC and plays a significant role in the function of T cells. This pilot study is the first to investigate the combined effect of gut microbiota and CYP3A5 on transplant outcomes.

*Methods: 10 kidney transplant recipients were enrolled from the George Washington University Hospital. Fecal samples were collected one week before and 1-3 months post transplantation. Whole bacterial DNA was sequenced using shotgun metagenomics. We analyzed the change in abundance of bacterial species. Blood samples were collected for sequencing of CYP3A5 and dd-cfDNA AlloSure testing. TAC levels were collected from electronic health records. Rosendaal method was used to calculate TTR. Coefficient of Variance was used to measure TV.

*Results: Change in Shannon diversity, change in relative abundance of species and Jaccard dissimilarity index were plotted against TV, TTR and dd-cfDNA. Pearson correlation coefficient was calculated for bivariate analysis. Association between TV and change in relative abundance of Bacteroides (r=0.56, p=0.08), Phocaeicola vulgatus (r=0.61, p=0.05), Prevotella (r=-0.57, p=0.08) and Ruminococcus (r=-0.51, p=0.10). dd-cfDNA was associated with change in relative abundance of Lachnospiraceae (r=-0.70, p=0.03). Jaccard dissimilarity index was positively associated with TV (r=0.52, p=0.10). All patients were high expressers of CYP3A5. TTR did not show any association with diversity indexes or bacterial species.

*Conclusions: Since all patients were high expressers of CYP3A5, the genetic effect of metabolization of TAC was controlled. If we attempt to reduce TV, we should focus on nutritional treatments which preserve the pre-transplant bacterial composition. Particularly, higher TV was associated with increase in the relative abundance of Bacteroides and Phocaeicola vulgatus and decrease in the relative abundance of Ruminococcus and Prevotella. Elevated abundance of Bacteroides is known to be associated with increased risk of IgA and membranous nephropathy. Thus, attempts to reduce TV could result in lowering the abundance of Bacteroides and risk of IgA. Patients with higher dd-cfDNA lost significant amount of Lachnospiraceae. Abundance of Lachnospiraceae is associated with decreased lethality from graft-versus-host disease in allogenic blood/marrow transplantation and higher survival rate by its anti-inflammatory effect through induction of regulatory T cells. We believe reduction in Lachnospiraceae could indicate a probability of active rejection.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Nayebpour M, Koizumi N, Melancon J, Hasan M. The Role of Gut Microbiota in Tacrolimus Blood Level Fluctuation, Time in Therapeutic Range and AlloSure Donor Derived Cell-Free DNA, Controlling for CYP3A5 [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/the-role-of-gut-microbiota-in-tacrolimus-blood-level-fluctuation-time-in-therapeutic-range-and-allosure-donor-derived-cell-free-dna-controlling-for-cyp3a5/. Accessed May 28, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences